Rare Disease Report
Physicians
Physicians
Patients & Caregivers

Toronto Mayor Rob Ford Diagnosed with Rare Cancer

SEPTEMBER 17, 2014
RDR Staff

Toronto mayor Rob Ford has been diagnosed with malignant pleomorphic liposarcoma and is undergoing treatment at Toronto’s Mount Sinai Hospital.
 
According to Dr Zane Cohen, who is leading Ford’s medical treatment, the malignant tumor has about 60 different cell types and arises from soft tissue (ie, no specific organ). The main tumor is in the abdomen and is approximately 12 cm2 in size and a smaller growth is present in the left hip/buttock (approx. 2 cm2).

The treatment scheduled for mayor Ford will be aggressive, starting with in-hospital chemotherapy for 3 days followed by a 18-day washout period and the cycle repeated. Details of what chemotherapeutic agents will be used were not provided.  Following the 2 cycles of chemotherapy, further assessment will be taken to determine the next course of treatment (i.e., more chemotherapy, radiation therapy, surgery, other). 

During a press conference, Dr Cohen noted that the type of sarcoma mayor Ford has is more responsive to chemotherapy than most but he cautioned that they will have a better understanding of the
mayor’s prognosis following the two cycles of chemotherapy. Since it is a very rare and varied tumor, the success rates for treating malignant liposarcomas is not well documented.

Prime Minister of Canada, Stephen Harper stated,  “The thoughts and prayers of all Canadians are with Mr. Ford and his family at this difficult time,” adding, “We wish him a speedy and complete recovery and are certain that he will take on this fight with all of his characteristic tenacity and energy.”


Image of Rob Ford talking to the press courtesy wikimedia commons.

Copyright © RareDR 2013-2017 Rare Disease Communications. All Rights Reserved.